67 related articles for article (PubMed ID: 8621941)
1. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
[TBL] [Abstract][Full Text] [Related]
2. Slow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivo.
Suzuki Y; Gatanaga H; Tachikawa N; Oka S
PLoS One; 2014; 9(2):e86479. PubMed ID: 24516533
[TBL] [Abstract][Full Text] [Related]
3. A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement.
Jia L; Xu Y; Zhang C; Wang Y; Chong H; Qiu S; Wang L; Zhong Y; Liu W; Sun Y; Qiao F; Tomlinson S; Song H; Zhou Y; He Y
Virol J; 2010 Jun; 7():142. PubMed ID: 20584336
[TBL] [Abstract][Full Text] [Related]
4. Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro.
Abdel-Motal UM; Sarkis PT; Han T; Pudney J; Anderson DJ; Zhu Q; Marasco WA
PLoS One; 2011; 6(10):e26473. PubMed ID: 22031835
[TBL] [Abstract][Full Text] [Related]
5. Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.
Benlarbi M; Richard J; Bourassa C; Tolbert WD; Chartrand-Lefebvre C; Gendron-Lepage G; Sylla M; El-Far M; Messier-Peet M; Guertin C; Turcotte I; Fromentin R; Verly MM; Prévost J; Clark A; Mothes W; Kaufmann DE; Maldarelli F; Chomont N; Bégin P; Tremblay C; Baril JG; Trottier B; Trottier S; Duerr R; Pazgier M; Durand M; Finzi A
J Infect Dis; 2024 Mar; 229(3):763-774. PubMed ID: 38035854
[TBL] [Abstract][Full Text] [Related]
6. Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.
Kuznetsov YG; Victoria JG; Robinson WE; McPherson A
J Virol; 2003 Nov; 77(22):11896-909. PubMed ID: 14581526
[TBL] [Abstract][Full Text] [Related]
7. gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity.
Tan S; Li W; Yang C; Zhan Q; Lu K; Liu J; Jin YM; Bai JS; Wang L; Li J; Li Z; Yu F; Li YY; Duan YX; Lu L; Zhang T; Wei J; Li L; Zheng YT; Jiang S; Liu S
Cell Mol Immunol; 2024 May; 21(5):479-494. PubMed ID: 38443447
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors.
Ireland J; Segura J; Shi G; Buchwald J; Roth G; Shen TJ; Wang R; Ji X; Fischer ER; Moir S; Chun TW; Sun PD
Front Microbiol; 2024; 15():1385775. PubMed ID: 38572241
[TBL] [Abstract][Full Text] [Related]
9. Kinetic aspects of virus targeting by nanoparticles in vivo.
Zhdanov VP
J Biol Phys; 2021 Jun; 47(2):95-101. PubMed ID: 34080098
[TBL] [Abstract][Full Text] [Related]
10. Detection and functional resolution of soluble immune complexes by an FcγR reporter cell panel.
Chen H; Maul-Pavicic A; Holzer M; Huber M; Salzer U; Chevalier N; Voll RE; Hengel H; Kolb P
EMBO Mol Med; 2022 Jan; 14(1):e14182. PubMed ID: 34842342
[TBL] [Abstract][Full Text] [Related]
11. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome.
Devaux CA; Rolain JM; Raoult D
J Microbiol Immunol Infect; 2020 Jun; 53(3):425-435. PubMed ID: 32414646
[TBL] [Abstract][Full Text] [Related]
12. Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
Wiredja DD; Tabler CO; Schlatzer DM; Li M; Chance MR; Tilton JC
Retrovirology; 2018 Jul; 15(1):44. PubMed ID: 29970186
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.
Ran X; Ao Z; Trajtman A; Xu W; Kobinger G; Keynan Y; Yao X
Sci Rep; 2017 Aug; 7(1):9487. PubMed ID: 28842659
[TBL] [Abstract][Full Text] [Related]
14. Quantitative phosphoproteomics reveals extensive cellular reprogramming during HIV-1 entry.
Wojcechowskyj JA; Didigu CA; Lee JY; Parrish NF; Sinha R; Hahn BH; Bushman FD; Jensen ST; Seeholzer SH; Doms RW
Cell Host Microbe; 2013 May; 13(5):613-623. PubMed ID: 23684312
[TBL] [Abstract][Full Text] [Related]
15. HIV reservoirs and latency models.
Pace MJ; Agosto L; Graf EH; O'Doherty U
Virology; 2011 Mar; 411(2):344-54. PubMed ID: 21284992
[TBL] [Abstract][Full Text] [Related]
16. Macrophage signaling in HIV-1 infection.
Herbein G; Gras G; Khan KA; Abbas W
Retrovirology; 2010 Apr; 7():34. PubMed ID: 20380698
[TBL] [Abstract][Full Text] [Related]
17. X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells.
Jones KL; Roche M; Gantier MP; Begum NA; Honjo T; Caradonna S; Williams BR; Mak J
J Biol Chem; 2010 Jun; 285(24):18603-14. PubMed ID: 20371602
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.
Agosto LM; Yu JJ; Dai J; Kaletsky R; Monie D; O'Doherty U
Virology; 2007 Nov; 368(1):60-72. PubMed ID: 17631931
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.
Swiggard WJ; Baytop C; Yu JJ; Dai J; Li C; Schretzenmair R; Theodosopoulos T; O'Doherty U
J Virol; 2005 Nov; 79(22):14179-88. PubMed ID: 16254353
[TBL] [Abstract][Full Text] [Related]
20. The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.
Darcissac EC; Truong MJ; Dewulf J; Mouton Y; Capron A; Bahr GM
J Virol; 2000 Sep; 74(17):7794-802. PubMed ID: 10933686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
